Home
Journal Information
About Journal
Founders
Call for Papers
Advantages of Publish
Editorial Office
For Reviewers
Contact Us
Create Account
Login
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2228-5652
eISSN
:
2228-5660
Bioimpacts
. 2023;13(3): 255-267. doi:
10.34172/bi.2023.25298
PMID:
37431477
PMCID:
PMC10329750
Original Article
Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells
Mitra Torabi
1
,
2
, Ayuob Aghanejad
1
* , Pouria Savadi
3
, Abolfazl Barzegari
1
, Yadollah Omidi
4
, Jaleh Barar
4
*
Cited by CrossRef: 2
1- Dehghan S, Naghipour A, Anbaji F, Golshanrad P, Mirazi H, Adelnia H, Bodaghi M, Far B. Enhanced in vitro and in vivo anticancer activity through the development of Sunitinib-Loaded nanoniosomes with controlled release and improved uptake.
International Journal of Pharmaceutics
. 2023;640:122977
[Crossref]
2- Estirado S, Díaz-García D, Fernández-Delgado E, Viñuelas-Zahínos E, Gómez-Ruiz S, Prashar S, Rodríguez A, Luna-Giles F, Pariente J, Espino J. Melatonin Derivative-Conjugated Formulations of Pd(II) and Pt(II) Thiazoline Complexes on Mesoporous Silica to Enhance Cytotoxicity and Apoptosis against HeLa Cells.
Pharmaceutics
. 2024;16(1):92
[Crossref]
Submit Your Paper
Instructions for Authors
Aims and Scope
Editorial Board
Editorial Policies
Publication Ethics Policies
Editorial Board Policy
Abstracting and Indexing
Archive